EVALUATION OF SUBCUTANEOUS (SC) VERSUS INTRAVENOUS (IV) PALONOSETRON IN CANCER PATIENTS TREATED WITH PLATINUM-BASED CHEMOTHERAPY: A RANDOMIZED PHARMACOKINETIC ASSAY

被引:0
|
作者
Arevalo, E. [1 ]
Del Barrio, A. [1 ]
Sadaba, B. [1 ]
Campanero, M. A. [1 ]
Azanza, J. R. [1 ]
Gurpide, A. [1 ]
Lopez Picazo, J. M. [1 ]
Martin Algarra, S. [1 ]
Perez Gracia, J. L. [1 ]
机构
[1] Univ Navarra Clin, Pamplona, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:508 / 509
页数:2
相关论文
共 50 条
  • [31] Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.
    Sofia Karageorgopoulou
    Ioannis D. Kostakis
    Maria Gazouli
    Sonia Markaki
    Marios Papadimitriou
    Evangelos Bournakis
    Meletios-Athanassios Dimopoulos
    Christos A Papadimitriou
    BMC Cancer, 17
  • [32] Genomic profiling as predictor of toxicity in patients with advanced colorectal cancer treated with platinum-based chemotherapy.
    Park, DJ
    Yun, J
    Yang, DY
    Iqbal, S
    Press, O
    Groshen, S
    Gordon, M
    Zhang, W
    Lenz, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 276S - 276S
  • [33] Prognostic values of DNA mismatch repair genes in ovarian cancer patients treated with platinum-based chemotherapy
    Zhao, Chuchu
    Li, Saisai
    Zhao, Menghuang
    Zhu, Haiyan
    Zhu, Xueqiong
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2018, 297 (01) : 153 - 159
  • [34] Pharmacogenomics in lung cancer:: an analysis of DNA repair gene expression in patients treated with platinum-based chemotherapy
    García-Campelo, R
    Alonso-Curbera, G
    Aparicio, LMA
    Rosell, R
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (12) : 2015 - 2026
  • [35] Topotecan plus Platinum-Based Chemotherapy versus Etoposide plus Platinum-Based Chemotherapy for Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    He, Mengyu
    Wu, Bingxuan
    Liu, Qiangyun
    Fang, Zige
    Liu, Miaowen
    Yi, Fengming
    Wei, Yiping
    Peng, Jinhua
    Zhang, Wenxiong
    CHEMOTHERAPY, 2021, 66 (04) : 113 - 123
  • [36] Prognostic value of CTCs in advanced NSCLC patients treated with platinum-based chemotherapy
    Calabuig-Farinas, S.
    Muinelo-Romay, L.
    Abalo, A.
    Lago, R.
    Mosqueda, M.
    Rodriguez Lopez, C.
    Escorihuela, E.
    Gallach Garcia, S.
    Garcia, J.
    Blasco, A.
    Jantus-Lewintre, E.
    Lopez, R.
    Camps, C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [37] Hyperglycemia crisis in head and neck cancer patients with platinum-based chemotherapy
    Huang, Chien-Yu
    Lin, Yaoh-Shiang
    Liu, Yu-Hsi
    Lin, Sheng-Chiao
    Kang, Bor-Hwang
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2018, 81 (12) : 1060 - 1064
  • [38] VIMENTINE AS A PREDICTIVE MARKER OF PLATINUM-BASED CHEMOTHERAPY IN OVARIAN CANCER PATIENTS
    Bogush, T.
    Dudko, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1408 - 1408
  • [39] A PHASE III TRIAL OF RH-ENDOSTATIN PLUS PLATINUM-BASED CHEMOTHERAPY VERSUS PLATINUM-BASED CHEMOTHERAPY IN PREVIOUSLY UNTREATED NON-SMALL CELL LUNG CANCER PATIENTS
    Zhou, J.
    Xiang, Y.
    Gao, B.
    Chen, W.
    Li, Q.
    Wan, H.
    RESPIROLOGY, 2011, 16 : 147 - 147
  • [40] Efficacy of taxane and platinum-based chemotherapy guided by extreme drug resistance assay in patients with epithelial ovarian cancer
    Joo, Won Deok
    Lee, Ji Young
    Kim, Jong Hyeok
    Yoo, Hang Jo
    Roh, Hyun Jin
    Park, Jeong-Yeol
    Kim, Dae-Yeon
    Kim, Yong-Man
    Kim, Young-Tak
    Nam, Joo-Hyun
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2009, 20 (02) : 96 - 100